$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How many pills of ibrutinib should be taken a day? Is it necessary to adjust the daily dosage according to different conditions?
2026-02-01 22:25:32
Check Details
How long does it take to see the effects of ruxolitinib tablets? What should patients pay attention to when taking it?
2026-02-01 22:25:32
Check Details
Which class of antibacterial drugs does clofazimine belong to? What are its mechanisms of action and indications?
2026-02-01 22:25:32
Check Details
What is the usage and dosage of gosatuzumab (Todavi)? How to take it correctly according to the doctor's advice?
2026-02-01 22:25:32
Check Details
How to buy evantumumab? How can patients obtain this drug?
2026-02-01 22:25:32
Check Details
How does Glasgib/Glasgib compare to traditional chemotherapy drugs?
2026-02-01 22:25:32
Check Details
Real-world data supports first-line use of avelumab plus axitinib/axitinib in advanced renal cell carcinoma
2026-02-01 22:25:32
Check Details
Duration of use of trametinib and dabrafenib and related precautions
2026-02-01 22:25:32
Check Details
Imatinib/Gleevec Medication Guidelines
2026-02-01 22:25:32
Check Details
Ruxolitinib/Ruxolitinib Cream: Reveal its magical efficacy and mechanism of action!
2026-02-01 22:25:32
Check Details
Usage and dosage of Jisandai/Bingtonsha: How to use medicine scientifically to improve efficacy
2026-02-01 22:25:32
Check Details
Domestic listing status and medical insurance price of Glasgib/Grasgib
2026-02-01 22:25:32
Check Details
1
2
...
1387
1388
1389
1390
1391
1392
1393
...
10212
10213
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Venetoclax (Venetoclax): Balancing Precision with Risk Management in Hematologic Malignancies
2
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
3
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
4
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment
5
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
6
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
7
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
8
Vibegron 2026 Research Updates: New Evidence for Overactive Bladder Treatment
9
Elafibranor for Cholestatic Liver Diseases: Efficacy Maintenance and Drug Resistance Analysis
10
Benzgalantamine (Zunveyl) for Alzheimer's Disease: Efficacy and Optimal Treatment Stages
11
Loargys(Pegzilarginase-nbln) Complete Medication Guide: Pre-Treatment Assessment, Monitoring and Home Administration
12
Plerixafor Complete Side Effect Guide: Adverse Reaction Classification and Professional Management